MedTrace Logo

Comparison of the Vividtrac™ and Other Videolaryngoscopes in Clinical Practice

NCT03271008 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2017-09-01

No results posted yet for this study

Summary

Comparison of various videolaryngoscope devices (Vividtrac™ and KingVision™) and direct laryngoscopy with Macintosh blade regarding laryngoscopy time, intubation time, intubation success rate, percentage of visible glottic opening (POGO score) in elective and acute clinical anaesthesiology practice.

Conditions

  • Intubation;Difficult

Interventions

DEVICE

Direct laryngoscopy

During the induction of general anaesthesia, the first attempt to achieve a secured airway is carried out using a size 4 (or size 3 if necessary) Macintosh blade direct laryngoscope.

DEVICE

Vividtrac videolaryngoscope

During the induction of general anaesthesia, the first attempt to achieve a secured airway is carried out using a Vividtrac videolaryngoscope connected to a tablet or smartphone.

DEVICE

KingVision videolaryngoscope

During the induction of general anaesthesia, the first attempt to achieve a secured airway is carried out using a KingVision videolaryngoscope.

Sponsors & Collaborators

  • University of Pecs

    lead OTHER

Principal Investigators

  • Bálint Nagy, MD PhD · Department of Anesthesiology and Intensive Therapy, University of Pécs, Hungary

  • Szilárd Rendeki, MD · Department of Anesthesiology and Intensive Therapy, University of Pécs, Hungary

  • Lajos Bogár, MD PhD DSc · Department of Anesthesiology and Intensive Therapy, University of Pécs, Hungary

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2018-07-01
Completion
2018-07-01

Countries

  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03271008 on ClinicalTrials.gov